• 1. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Recent Advances in the Study of 4-(3-Aminophenyl)-2-methoxyphenol (CAS: 1261987-94-3) in Chemical Biology and Pharmaceutical Research

The compound 4-(3-Aminophenyl)-2-methoxyphenol (CAS: 1261987-94-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. This phenolic derivative, characterized by its unique structural features, has been the subject of multiple studies aimed at elucidating its biological activities, mechanisms of action, and potential as a lead compound in drug development. The current research landscape surrounding this molecule reflects a growing interest in its pharmacological properties, particularly in the context of inflammation, oxidative stress, and cancer therapy.

Recent studies have focused on the synthesis and characterization of 4-(3-Aminophenyl)-2-methoxyphenol derivatives to enhance their bioavailability and target specificity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that structural modifications at the amine and methoxy positions could significantly improve the compound's pharmacokinetic profile while maintaining its biological activity. The research team employed computational modeling and in vitro assays to identify optimal derivatives with enhanced binding affinity to molecular targets involved in inflammatory pathways.

In the context of cancer research, 4-(3-Aminophenyl)-2-methoxyphenol has shown promising results as a potential anti-proliferative agent. A recent investigation published in Bioorganic & Medicinal Chemistry Letters revealed that the compound exhibits selective cytotoxicity against certain cancer cell lines, particularly those with overexpression of reactive oxygen species (ROS). The study proposed that the molecule's mechanism of action involves the modulation of redox homeostasis, leading to cancer cell apoptosis. These findings were supported by comprehensive proteomic analysis and ROS detection assays.

The compound's potential applications in neurodegenerative diseases have also been explored. Research conducted at several academic institutions has demonstrated that 4-(3-Aminophenyl)-2-methoxyphenol can cross the blood-brain barrier and exhibit neuroprotective effects in cellular models of Parkinson's disease. The neuroprotective properties appear to be mediated through the compound's antioxidant activity and its ability to modulate key signaling pathways involved in neuronal survival.

From a chemical biology perspective, recent work has focused on understanding the molecular interactions of 4-(3-Aminophenyl)-2-methoxyphenol with biological targets. Advanced techniques such as surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) have been employed to characterize the binding kinetics and thermodynamics of the compound with various proteins. These studies have provided valuable insights into structure-activity relationships that could guide future drug design efforts.

Despite these promising developments, challenges remain in the clinical translation of 4-(3-Aminophenyl)-2-methoxyphenol-based therapeutics. Current research is addressing issues related to metabolic stability, potential toxicity profiles, and formulation optimization. Several pharmaceutical companies have initiated preclinical development programs based on derivatives of this compound, with particular focus on its application in chronic inflammatory conditions and certain oncology indications.

The growing body of research on 4-(3-Aminophenyl)-2-methoxyphenol (CAS: 1261987-94-3) underscores its potential as a versatile scaffold in medicinal chemistry. Future directions in this field are likely to include more extensive structure-activity relationship studies, advanced formulation development, and comprehensive preclinical evaluation across multiple disease models. As the understanding of this compound's biological activities continues to expand, it may emerge as an important pharmacophore in the development of novel therapeutic agents.

• 230962-39-7(3'-Methoxy-2-methyl1,1'-biphenyl-4-amine)
• 1261988-76-4(3'-Amino-5-methoxy[1,1'-biphenyl]-3-ol)
• 400748-70-1(3-(3-Methoxyphenyl)aniline)
• 471240-46-7([1,1'-BIPHENYL]-3,4-DIAMINE, 3'-METHOXY-)
• 78617-18-2(2-(3,4-DIMETHOXYPHENYL)ANILINE)
• 471240-45-6(2-氨基-4-（4-甲氧基苯基）苯胺)
• 1137-77-5(4'-Methoxy-1,1'-biphenyl-4-amine)
• 207287-79-4(3'-Methoxy-1,1'-biphenyl-4-amine hydrochloride)
• 53059-28-2(4'-methoxy-1,1'-biphenyl-3-amine)
• 811842-36-1(3-(3-Methoxyphenyl)aniline, Hydrochloric Acid Salt)